Anti-HER2 treatment in breast cancer - Bentouati, Abdelkader
40,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
20 °P sammeln
  • Broschiertes Buch

HER2-positive breast cancer represents a major challenge in oncology, but also a remarkable therapeutic success story. This book offers a comprehensive and up-to-date exploration of anti-HER2 therapy, from fundamental discoveries in molecular biology to its practical application in patient management.Much more than a simple review of treatments, this book dives to the heart of HER2 biology, deciphering the molecular mechanisms that make it such a crucial therapeutic target. It traces the meteoric evolution of anti-HER2 therapies, from the first monoclonal antibodies to the latest generation of antibody-drug conjugates and tyrosine kinase inhibitors.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
HER2-positive breast cancer represents a major challenge in oncology, but also a remarkable therapeutic success story. This book offers a comprehensive and up-to-date exploration of anti-HER2 therapy, from fundamental discoveries in molecular biology to its practical application in patient management.Much more than a simple review of treatments, this book dives to the heart of HER2 biology, deciphering the molecular mechanisms that make it such a crucial therapeutic target. It traces the meteoric evolution of anti-HER2 therapies, from the first monoclonal antibodies to the latest generation of antibody-drug conjugates and tyrosine kinase inhibitors.
Autorenporträt
Dr Abdelkader Bentouati, algierski onkolog od 20 lat (EHU Oran). Specjalista w leczeniu anty-HER2. Jego ksi¿¿ka: niezb¿dny przewodnik dla profesjonalistów.